Publications by authors named "Maxime Bucci"

Claim this Profile
mutation subtype switch in acute myeloid leukemia.
Benjamin Podvin, Romane Joudinaud, Christophe Roumier, Augustin Boudry, Laure Farnault, Maxime Bucci

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.
Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Augustin Boudry

Blood Cancer J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Augustin Boudry, Sasha Darmon, Nicolas Duployez, Martin Figeac, Sandrine Geffroy, Maxime Bucci

BMC Bioinformatics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Augustin Boudry, Sasha Darmon, Nicolas Duployez, Martin Figeac, Sandrine Geffroy, Maxime Bucci

BMC Bioinformatics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
Matthieu Duchmann, Romane Joudinaud, Augustin Boudry, Justine Pasanisi, Giuseppe Di Feo, Maxime Bucci

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
Nicolas Duployez, Jordane Demonchy, Céline Berthon, Julien Goutay, Morgan Caplan, Maxime Bucci

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.
Yann Ferret, Nicolas Boissel, Nathalie Helevaut, Jordan Madic, Olivier Nibourel, Maxime Bucci

Haematologica· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group.
Alice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, Myriam Labopin, Arnaud Petit, Maxime Bucci

Hemasphere· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21).
Nicolas Duployez, Jean-Baptiste Micol, Nicolas Boissel, Arnaud Petit, Sandrine Geffroy, Maxime Bucci

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, Arnaud Petit, Maxime Bucci

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis